The Trendlines Group Ltd. (42T.SI)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | -4 | 2 | 4 | 4 | 2 | 2 | - | - |
| Operating profit | $m | -0 | - | ||||||
| Net profit | $m | -5 | 7 | -14 | -34 | -9 | 2 | - | - |
| EPS reported | $ | 0.00 | - | ||||||
| Operating cashflow per share | $ | -0.01 | - | ||||||
| Capex per share | $ | 0.00 | - | ||||||
| FCF per share | $ | -0.01 | - | ||||||
| Free cash flow | $m | -6 | - | ||||||
| Net debt | $m | -1 | - | ||||||
| Book value equity | $m | 78 | - | ||||||
| Book value per share | $ | 0.07 | - | ||||||
| Number of shares | m | 1,167.88 | - | ||||||
| DPS (TTM paid) | $ | 0.00 | - |
Financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 35.46 | - | ||||||
| P/B LTM | x | 0.85 | - | ||||||
| P/S LTM | x | 33.32 | - | ||||||
| P/FCF LTM | x | -11.24 | - | ||||||
| EV/EBITDA LTM | x | 31.29 | - | ||||||
| EV/Sales LTM | x | 33.54 | - | ||||||
| Earnings Yield LTM | % | +2.82% | - | ||||||
| FCF Yield | % | -8.89% | - | ||||||
| Quality | |||||||||
| ROE | % | +2.49% | - | ||||||
| ROIC | % | -0.30% | - | ||||||
| Operating margin | % | -13.02% | - | ||||||
| Gross margin | % | +17.26% | - | ||||||
| FCF/Sales | % | -296.37% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +15.67% | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | - | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | - | ||||||
| FCF/Debt | x | -1.10 | - | ||||||
| Net Debt/EBITDA | x | 0.20 | - | ||||||
| EBIT/Net interest | x | -2.71 | - | ||||||
| Net debt/market cap | % | +6.44% | - | ||||||
| Net debt/Equity | x | -0.01 | - | ||||||
| Gross debt/equity | x | 0.07 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
The Trendlines Group Ltd. is a private equity and venture capital firm focused on commercializing innovative technologies. They specialize in early-stage investments, ranging from incubation and seed funding to start-up and even later-stage venture capital for more established companies. Their investment strategy targets high-growth sectors such as food, medical technology (medtech), clean technology, agrifood, agritechnology, and life sciences, specifically emphasizing medical devices, biotechnology, and pharmaceuticals. They also consider opportunities in security, general medical fields, and information technology. The firm primarily seeks to invest in companies located in Israel and Singapore. Beyond financial backing, Trendlines offers extensive support to entrepreneurs, encompassing business incubation, market strategy development, research and development guidance, commercialization services, business development, funding strategies, administrative assistance, and marketing communications. The preferred exit routes for their investments include mergers and acquisitions, public stock listings, or other strategic dispositions of holdings. To mitigate the risks inherent in developing new businesses, Trendlines leverages its own capital alongside government funding. The firm actively participates in all aspects of its portfolio companies, from technological innovation to comprehensive business construction. Founded in 1993, The Trendlines Group Ltd. is headquartered in M.P. Misgav, Israel, and maintains additional offices in Tel Aviv, Israel; Beijing, China; and Singapore.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
The Trendlines Group Ltd. (42T.SI)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
The Trendlines Group Ltd. is a private equity and venture capital firm focused on commercializing innovative technologies. They specialize in early-stage investments, ranging from incubation and seed funding to start-up and even later-stage venture capital for more established companies. Their investment strategy targets high-growth sectors such as food, medical technology (medtech), clean technology, agrifood, agritechnology, and life sciences, specifically emphasizing medical devices, biotechnology, and pharmaceuticals. They also consider opportunities in security, general medical fields, and information technology. The firm primarily seeks to invest in companies located in Israel and Singapore. Beyond financial backing, Trendlines offers extensive support to entrepreneurs, encompassing business incubation, market strategy development, research and development guidance, commercialization services, business development, funding strategies, administrative assistance, and marketing communications. The preferred exit routes for their investments include mergers and acquisitions, public stock listings, or other strategic dispositions of holdings. To mitigate the risks inherent in developing new businesses, Trendlines leverages its own capital alongside government funding. The firm actively participates in all aspects of its portfolio companies, from technological innovation to comprehensive business construction. Founded in 1993, The Trendlines Group Ltd. is headquartered in M.P. Misgav, Israel, and maintains additional offices in Tel Aviv, Israel; Beijing, China; and Singapore.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free